FibroBiologics announced the filing of a patent application with the United States Patent Office covering the use of fibroblast cell-based technology in an adhesive bandage for wound healing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBLG:
- FibroBiologics Files 2024 Second Quarter Report
- FibroBiologics to Present at JonesTrading Healthcare Summit 2024
- FibroBiologics reports preliminary proof of concept for thymus organoid tech
- FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
- Fibrobiologics Inc trading resumes